Aspirin use and p53 expression in colorectal cancer

Cancer Detection and Prevention

Volumn 22, Issue 3, 1998, Pages 213-218

  Freedman, A N ^a   Michalek, A M ^a   Weiss, H A ^a   Zhang, Z F ^a   Marshall, J R ^a   Mettlin, C J ^a   Asirwatham, J E ^a   Petrelli, N J ^a   Caporaso, N E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Aspirin; Colorectal; Epidemiology; p53

Indexed keywords

ACETYLSALICYLIC ACID; PROTEIN P53;

ADENOCARCINOMA; AGED; ARTICLE; BIOSYNTHESIS; CHEMISTRY; COLORECTAL TUMOR; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RISK FACTOR; TUMOR SUPPRESSOR GENE; UNITED STATES;

ADENOCARCINOMA; ADMINISTRATION, ORAL; AGED; ASPIRIN; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; MALE; MIDDLE AGED; NEW YORK; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031970574     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1500.1998.0OA29.x     Document Type: Article

References (35)